Korean Journal of Physiology & Pharmacology

Papers
(The H4-Index of Korean Journal of Physiology & Pharmacology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe18
Lithium and exercise ameliorate insulin-deficient hyperglycemia by independently attenuating pancreatic α-cell mass and hepatic gluconeogenesis18
Chios gum mastic enhance the proliferation and odontogenic differentiation of human dental pulp stem cells16
Phytochemicals as promising agents in Axl-targeted cancer treatment16
Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models16
Differential expression of ORAI channels and STIM proteins in renal cell carcinoma subtypes: implications for metastasis and therapeutic targeting15
Cardioprotection via mitochondrial transplantation supports fatty acid metabolism in ischemia-reperfusion injured rat heart15
Effects of gas signaling molecule SO2 in cardiac functions of hyperthyroid rats14
Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice13
Hyaluronan-mediated motility receptor-mediated aerobic glycolysis enhances stem-like properties and chemoresistance in lung adenocarcinoma13
Cell-cell contacts via N-cadherin induce a regulatory renin secretory phenotype in As4.1 cells13
Effects of in vivo treatment with Kv7.4 activator, URO-K10, on the impaired relaxation of pulmonary arteries in the monocrotaline-induced pulmonary hypertensive rats13
Relation between heart rate variability and spectral analysis of electroencephalogram in chronic neuropathic pain patients12
Protective effect of 6′-Sialyllactose on LPS-induced macrophage inflammation via regulating Nrf2-mediated oxidative stress and inflammatory signaling pathways12
Chelidonine inhibits melanoma cell malignancy by inactivating TLR4/NF-κB and PI3K/AKT signaling pathways12
0.1131272315979